Veterinary Stereotactic Radiosurgery System Market Strategic Market Roadmap: Analysis and Forecasts 2025-2033

Key Insights

The size of the Veterinary Stereotactic Radiosurgery System Market was valued at USD 412.3 Million in 2023 and is projected to reach USD 768.34 Million by 2032, with an expected CAGR of 9.3% during the forecast period. The market for Veterinary Stereotactic Radiosurgery (SRS) System is centered on the advancement and acceptance of innovative medical technologies that offer precise, non-invasive treatment for animals, particularly pets such as dogs and cats. The modern technique of stereotactic radiosurgery involves directing precise radiation to target tumors or abnormal tissue, effectively minimizing harm to surrounding healthy tissue. This technology is especially beneficial for addressing cancers and neurological disorders in animals that are not suitable for conventional surgery. The rising occurrence of cancer and neurological diseases in pets, along with a higher need for advanced and less invasive treatment options, is fueling the market. Furthermore, the increasing utilization of pet medical services, enhanced understanding of veterinary cancer treatment, and developments in radiation therapy technologies all play a role in driving market expansion. Important actors in the industry consist of veterinary hospitals, specialized clinics, and research institutions that put resources into these cutting-edge technologies. With advancements in veterinary care, it is anticipated that the Veterinary Stereotactic Radiosurgery System Market will expand, leading to better results for animals with intricate medical issues.

Veterinary Stereotactic Radiosurgery System Market Concentration & Characteristics

The market exhibits a moderate concentration, with key players holding significant market share. However, smaller players are emerging, offering competitive solutions.

Innovation: The market is characterized by continuous innovation, with companies developing advanced radiotherapy technologies to enhance treatment outcomes.

Regulations: Stringent regulations govern the use of radiation in veterinary medicine, ensuring patient safety and minimizing environmental impact.

End-user concentration: Veterinary hospitals account for a majority of market share, with veterinary clinics and other end-users contributing to the remaining share.

M&A activity: Merger and acquisition activity remains moderate, as companies seek to expand their product offerings and geographical reach.

Veterinary Stereotactic Radiosurgery System Market Trends

• Rising adoption of image-guided radiotherapy (IGRT): IGRT enables precise targeting of tumors, reducing treatment time and side effects.
• Increased use of CyberKnife and Gamma Knife systems: These systems deliver highly focused radiation beams, minimizing damage to surrounding tissues.
• Growing focus on veterinary oncology: Specialized veterinary oncology centers are emerging, providing comprehensive cancer care for pets.
• Emphasis on research and development: Companies are investing in research to develop more effective and less invasive treatments for veterinary cancer.

Key Region or Country & Segment to Dominate the Market

• North America: Maintains its dominance due to the strong presence of specialized veterinary facilities, advanced technology adoption, and a large pet-owning population.
• Linear Accelerators (Linacs): Continues to hold the largest product segment, attributed to their precision, affordability, and versatility for various veterinary radiosurgery applications.
• Brain and Spinal Tumors: Remains the largest application segment, as these tumors commonly affect cats and dogs and benefit significantly from stereotactic radiosurgery.
• Veterinary Specialty Hospitals: Retains the largest end-user segment due to their specialized equipment and trained personnel, enabling the execution of complex stereotactic radiosurgery procedures.
• Emerging Markets: Regions such as Asia-Pacific, Latin America, and the Middle East are expected to witness increased market growth due to increasing pet ownership, rising awareness of veterinary care, and advancements in veterinary technology.

Veterinary Stereotactic Radiosurgery System Market Product Insights

The market offers a range of products:

• Linear Accelerators (Linac): Versatile and cost-effective, used for various radiotherapy treatments.
• CyberKnife: Advanced system with robotic arm, enabling precise delivery of radiation.
• Gamma Knife: Non-invasive system for treating small, inoperable brain tumors.

Veterinary Stereotactic Radiosurgery System Market Regional Insights

• North America: U.S. and Canada dominate due to high veterinary healthcare spending and advanced veterinary infrastructure.
• Europe: Germany, UK, and France are key markets, driven by high pet ownership rates and government initiatives.
• Asia Pacific: Japan and China are emerging markets with growing veterinary healthcare sectors.
• Latin America: Brazil and Mexico are expanding markets, with increasing veterinary specialization.
• Middle East and Africa: Saudi Arabia and South Africa are leading markets due to rising pet ownership and healthcare investment.

Driving Forces

• Increased prevalence of cancer in pets
• Advancements in veterinary oncology
• Rising demand for specialized veterinary care
• Government initiatives promoting animal welfare

Challenges and Restraints

• High cost of equipment and treatment
• Availability of trained veterinary professionals
• Limited access to veterinary healthcare in certain regions

Emerging Trends

• Televeterinary services for remote treatment
• Development of more affordable treatment options
• Increased focus on preventive care to reduce cancer incidence

Market Segmentation

Product

• Linear Accelerators (Linac)
• CyberKnife
• Gamma Knife

Application

• Brain Tumor
• Spinal Tumor
• Other Applications

End-user

• Veterinary Hospitals
• Veterinary Clinics
• Other End-users

Veterinary Stereotactic Radiosurgery System Industry News

In January 2023, CVS Group installed a cutting-edge Elekta Infinity linear accelerator at its Bristol Vet Specialists referrals hospital. This advanced technology enables the hospital to provide state-of-the-art image-guided radiation therapy for cancer treatment in cats and dogs.

Leading Players in the Veterinary Stereotactic Radiosurgery System Market

• Accuray Incorporated
• Elekta AB
• Varian Medical Systems